Immunome IMNM
NASDAQ IMNM
$17.92 +1.15 (+6.86%)
At close: Oct 20, 2026 · 4:00 PM EDT

Immunome (IMNM) EV to CFO (2023)

Updated

Immunome's (IMNM) EV to CFO stood at 3.51 in Q3 2023, down 74.3% from the prior quarter.

Analysis

Immunome (IMNM) EV to CFO (2023) Analysis & Trends

On a TTM basis, Immunome's EV to CFO came in at -28.65 as of Sep 30, 2023.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Immunome 2.04 Bn 6.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 3.51
Jun 30, 2023 13.66
Mar 31, 2023 8.84
API Access

Immunome EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=IMNM&period=max&api_key=YOUR_API_KEY